abituzumab

abituzumab · EMD Serono Research & Development Institute, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for abituzumab, covering 2019-06-18 to 2019-06-18. Get the full timeline:

Most recent: Clinical Trial Update: Abituzumab in SSc-ILD [Phase 2]